Testosterone MDL Judge Denies Dismissal Of Contested Claims Against Belgian Defendant
(October 1, 2015, 1:59 PM EDT) -- CHICAGO — The Illinois federal judge overseeing the testosterone replacement therapy multidistrict litigation on Sept. 30 denied dismissal of the plaintiffs’ contested claims of design defect, negligence and redhibition and ordered discovery into the court’s jurisdiction over a Belgian defendant and its U.S. subsidiary (In Re: Testosterone Replacement Therapy Product Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill., Eastern Div.).